Neuralink obtains FDA approval to begin clinical human trials of its brain computer interface
Neuralink has announced it received approval from the Food and Drug Administration (FDA) to launch a clinical study of its brain-computer interface (BCI) involving humans. Neuralink was founded by CEO Elon Musk in 2016, and […]